Showing results (131-140 of 231) with videos related to
Sort By:
Pageof 24
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2006
Consistent resting-state networks across healthy subjectsJ S Damoiseaux, S A R B Rombouts, F Barkhof, et al.Alzheimer Disease and Associated Disorders|December 28, 1999
Role of white matter lesions in cognitive impairment of vascular originL Pantoni, D Leys, F Fazekas, et al.Cerebral Circulation - Cognition and Behavior|November 3, 2022
Neuropsychiatric symptoms in patients with possible vascular cognitive impairment, does sex matter?L G Exalto, J M Boomsma, Ycp Sep, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1992
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlatesP Scheltens, D Leys, F Barkhof, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2004
The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementiaE F J Meulen, B Schmand, J P van Campen, et al.Neuroimage|October 19, 2004
Global and local gray matter loss in mild cognitive impairment and Alzheimer's diseaseG B Karas, P Scheltens, S A R B Rombouts, et al.AJNR. American Journal of Neuroradiology|September 22, 2007
Nonlinear changes in brain activity during continuous word repetition: an event-related multiparametric functional MR imaging studyR E Hagenbeek, S A R B Rombouts, D J Veltman, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 21, 2007
Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degenerationY A L Pijnenburg, S N M Schoonenboom, P D Mehta, et al.Brain : a Journal of Neurology|October 18, 2008
Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathologyA A Gouw, A Seewann, H Vrenken, et al.Brain : a Journal of Neurology|December 16, 1997
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosisF Barkhof, M Filippi, D H Miller, et al.Pageof 24